RPS’ director of pharmacy and membership experience is due to leave his role at the end of this month, following weeks of speculation.
Robbie Turner will leave the RPS executive team on 31 March, the organisation announced in a statement published on its website last night (24 March).
RPS did not clarify why Mr Turner would be leaving his role.
This comes after RPS announced this month (3 March) it was working on a proposal that would result in changes to the executive structure.
Following this, speculation circulated suggesting Mr Turner and Gail Fleming, its director of education, were to be made redundant as part of the restructure.
In response to the rumours on redundancies, Claire Anderson, president of RPS said that any changes to the executive team would not be about ‘cost savings’.
She also confirmed that ‘there would still be a leader on the executive with responsibility for delivering on our education strategy’, but made no mention of the future of Mr Turner's current role.
Paul Bennett, RPS’ chief executive, wished Mr Turner ‘all the best’ for the future and thanked him for his ‘excellent work’ since joining the organisation in 2017.
‘Once any changes to the executive team are agreed, you have my full commitment that we will update everyone on how any changes to our structure enable us to deliver our Royal Charter obligations and our 5-year strategy,’ he added.
This comes after criticism of the RPS for a lack of transparency around its decision to leave the International Pharmaceutical Federation (FIP).
Since then, FIP has disputed some of the membership fee claims made by RPS. In a statement, published on its website this week (22 March), FIP said RPS’ claim that it paid a FIP membership fee of £31,000 annually was incorrect, by asserting the membership fee for 2022 was instead ‘approximately’ £25,352.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.